Dr. Geoffrey Ira Shapiro MD Medical Oncologist

Dr. Geoffrey Shapiro is a medical oncologist in Boston, Massachusetts. He is affiliated with multiple hospitals in the area, including Boston Children's Hospital and Brigham and Women's Hospital. He received his medical degree from Weill Cornell Medical College of Cornell University and has been in practice for 26 years. Dr. Shapiro accepts several types of health insurance, listed below. He is one of 75 doctors at Boston Children's Hospital and one of 96 at Brigham and Women's Hospital who specialize in Medical Oncology.

Are you Dr. Geoffrey Shapiro? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: General Oncology

Clinical Interests: Pharmacology, Child development, Developmental Therapeutics Phase 1 Trials

Education & Medical Training

Beth Israel Deaconess Medical Center
Residency, Internal Medicine, 1988 - 1991

Brigham and Women's Hospital
Fellowship, Medical Oncology, 1991 - 1994

Weill Cornell Medical College of Cornell University
Class of 1988

Certifications & Licensure

American Board of Internal Medicine
Certified 23 years in Internal Medicine

American Board of Internal Medicine
Certified 19 years in Medical Oncology

MA State Medical License
Active through 2014

Publications & Presentations

Crizotinib as salvage and maintenance with allogeneic stem cell transplantation for refractory anaplastic large cell lymphoma.
Cleary, J. M.,Rodig, S.,Barr, P. M.,Shinagare, A. B.,Clark, J. W.,Shapiro, G. I.,Armand, P.

Co-Clinical Trials Demonstrate Superiority of Crizotinib to Chemotherapy in ALK-Rearranged Non-Small Cell Lung Cancer and Predict Strategies to Overcome Resistance.
Chen, Z.,Akbay, E.,Mikse, O.,Tupper, T.,Cheng, K.,Wang, Y.,Tan, X.,Altabef, A.,Woo, S. A.,Chen, L.,Reibel, J. B.,Janne, P. A.,Sharpless, N. E.,Engelman, J. A.,Shapiro, G. I.,Kung, A. L.,Wong, K. K.

Phase I Safety and Pharmacokinetic Study of the PI3K/mTOR Inhibitor SAR245409 (XL765) in Combination with Erlotinib in Patients with Advanced Solid Tumors.
Jänne, P. A.,Cohen, R. B.,Laird, A. D.,Macé, S.,Engelman, J. A.,Ruiz-Soto, R.,Rockich, K.,Xu, J.,Shapiro, G. I.,Martinez, P.,Felip, E.

See all 73 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • BCBS Massachusetts Blue Care Elect PPO
  • Great West PPO
  • Harvard Pilgrim HMO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • Tufts Health Plan PPO
  • UniCare PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.